Skip to content
DataLookout
Menu

NCT07540559

The Effect of Coffee Consumption on Balance

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 8 words Show 5 more changesShow less
    • Completed without a posted recruiting period
    • Primary completion date changed from estimate of May 1, 2027 to Aug 1, 2026
    • Study sites: 0 to 1
    • Start date changed from estimate of May 1, 2026 to Apr 3, 2026
    • Secondary endpoints: details revised at 1 of 1 entry
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Single Leg Stance Test
Timeframe: Single assessment at baseline
Y Balance Test
Timeframe: Single assessment at baseline
Timed Up and Go (TUG) Test
Timeframe: Single assessment at baseline
Tandem Walking Test
Timeframe: Single assessment at baseline

Secondary (1)

Borg Rating of Perceived Exertion (RPE) Scale

Arms and interventions

Low coffee consumption group

0-100 mg caffeine consumers.

Moderate coffee consumption group

100-300 mg caffeine consumers.

High coffee consumption group

\>300 mg caffeine consumers.

Other: Daily coffee consumption (self-reported exposure)

Sites

1 site in 1 country

  • Saglik Bilimleri UniversitesiIstanbul, Üsküdar, Turkey (Türkiye)